Nalaganje...
The heterogeneity of the kinetics of response to ipilimumab in metastatic melanoma: patient cases
Cytotoxic T lymphocyte antigen-4 (CTLA-4) is a negative regulator of T-cell mediated immune responses and is the target of new anti-tumor immunotherapy strategies. Ipilimumab is a fully human, antagonistic monoclonal antibody directed against CTLA-4. Results from preclinical and early clinical trial...
Shranjeno v:
| Main Authors: | , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Academy of Cancer
Immunology
2008
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2935787/ https://ncbi.nlm.nih.gov/pubmed/18198818 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|